Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
2020 | ACell, Inc. Announces CE Mark Approval | CI |
Financials (USD)
Sales 2018 | 89.22M | Sales 2019 | 101M | Capitalization | 340M |
---|---|---|---|---|---|
Net income 2018 | -3M | Net income 2019 | 1M | EV / Sales 2018 * | - |
Net cash position 2018 * | - | Net cash position 2019 * | - | EV / Sales 2019 * | - |
P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 13-03-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 01-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | - | |
Director/Board Member | 69 | 19-06-30 | |
Kyle C. Kerbawy
BRD | Director/Board Member | 77 | 15-07-31 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 340M | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.61% | 40.74B | |
+19.92% | 31.6B | |
+16.14% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- ACLL Stock